Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gastrointestinal Cancer
  •  Pancreatic Cancer
  •  Paediatric Cancers
  •  Endometrial Cancer
  •  Ovarian Cancer
  •  Palliative Care
  •  Blood Cancer
  •  Targeted Therapy

Abstract

Citation: Clin Oncol. 2024;9(1):2117.DOI: 10.25107/2474-1663-v9-id2117

Anti-Diabetic Drugs as Novel Avenues in Cancer Management

Rizwan A, Idris A, Shaikh H, Aqeel A and Farooqi H

Department of Biotechnology, Jamia Hamdard, New Delhi, India Department of Food Technology, Jamia Hamdard, New Delhi, India These authors contributed equally to this work

*Correspondance to: Humaira Farooqi 

 PDF  Full Text Review Article | Open Access

Abstract:

The International Diabetes Federation has highlighted the global rise in diabetes, impacting 463 million people, or 9.3% of the population, with projections indicating an increase to 700 million by 2045. There is a significant connection between diabetes, particularly type 2, and cancer risk due to impaired insulin signaling promoting abnormal cell growth. Antidiabetic medications regulating insulin show promise as adjuvants in cancer therapy, sparking growing interest in this area. This review provides a comprehensive overview of the complex relationship between antidiabetic drugs and cancer through epidemiological data, preclinical studies, and clinical trials examining the potential anti-cancer properties of drugs like metformin and SGLT-2 inhibitors. It also addresses controversies surrounding the effects of biguanides and SGLT-2 inhibitors on cancer treatment while identifying research gaps to promote extensive exploration into this topic and foster innovative treatment approaches. However, using antidiabetic drugs to fight cancer presents challenges such as optimizing dosing and managing side effects; thus, emphasizing continuous research for developing effective personalized treatment strategies (Figure 1).

Keywords:

Diabetes; Cancer; Anti-Diabetic Medications; Metformin; SGLT-2 Inhibitors; Insulin; Molecular Pathways; Epidemiology

Cite the Article:

Rizwan A, Idris A, Shaikh H, Aqeel A, Farooqi H. Anti-Diabetic Drugs as Novel Avenues in Cancer Management. Clin Oncol. 2024; 9: 2117..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Expression of the Oncoprotein E5 from Human papillomavirus and miR-203 in Pre-Cancer Lesions and Cervical Cancer
 Abstract  PDF  Full Text
Application of First-Line Steady-State Mobilization vs. Conventional Chemotherapy Mobilization for Peripheral Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients
 Abstract  PDF  Full Text
View More...